enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - leki immunosupresyjne - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - odporne surowicy i immunoglobuliny, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. zobacz rozdziały 4. 4 i 5.
lunsumio
roche registration gmbh - mosunetuzumab - chłoniak, mieszek włosowy - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - okulistyka - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
sumamed 100 mg/5 ml proszek do sporządzania zawiesiny doustnej
teva pharmaceuticals polska sp. z o.o. - azithromycinum - proszek do sporządzania zawiesiny doustnej - 100 mg/5 ml
sumamed forte 200 mg/5 ml proszek do sporządzania zawiesiny doustnej
teva pharmaceuticals polska sp. z o.o. - azithromycinum - proszek do sporządzania zawiesiny doustnej - 200 mg/5 ml
gluctam mr 30 mg 30 mg tabletki o zmodyfikowanym uwalnianiu
egis pharmaceuticals plc - gliclazidum - tabletki o zmodyfikowanym uwalnianiu - 30 mg
gluctam mr 60 mg 60 mg tabletki o zmodyfikowanym uwalnianiu
egis pharmaceuticals plc - gliclazidum - tabletki o zmodyfikowanym uwalnianiu - 60 mg
gliklazyd teva 60 mg tabletki o zmodyfikowanym uwalnianiu
teva pharmaceuticals polska sp. z o.o. - gliclazidum - tabletki o zmodyfikowanym uwalnianiu - 60 mg